Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study-Reference-Cited by-同舟云学术

Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study

Published:2023-10-27 Issue:1 Volume:22 Page:956-963
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Gong Yajie¹²³,Zhang Xi¹²³,Han Xue¹²³,Chen Baolan¹²³,Xu Yingxia¹²³,Huang Jitian¹²³,Yang Wenhan¹³,Fu Xi¹³,Wang Qiancui⁴,Li Zhongjun⁵,Wu Chunfeng⁶,Shen Tianran¹³,Fan Yuting¹²³,Dai Yingshi¹²³,Qiao Yaping⁷,Zeng Gang⁷,Zhang Jikai⁸,Chen Qingsong¹²³

Affiliation:

1. School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China

2. NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance, Guangdong Pharmaceutical University, Guangzhou, China

3. Guangdong Provincial Engineering Research Center of Public Health Detection and Assessment, Guangdong Pharmaceutical University, Guangzhou, China

4. Obstetrics and Gynecology, Guangzhou Baiyun District Maternal and Child Health Hospital, Guangzhou, China

5. Dongguan Hospital, Southern Medical University, Guangzhou, China

6. Obstetrics and Gynecology, Shenzhen LongHua District Maternity & Child Healthcare Hospital, Shenzhen, China

7. Sinovac Biotech Co. Ltd, Beijing, China

8. Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China

Funder

Medical Science and Technology Foundation of Guangdong Province

Guangdong Medical Products Administration

Exposure to SARS-CoV-2 vaccine before or during pregnancy and adverse pregnancy outcomes: a cohort study

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2272655

Reference31 articles.

1. WHO COVID-19 Dashboard. Geneva: World Health Organization. 2020 [cited 2023 Aug]; Available online https://covid19.who.int/

2. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

5. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study